The make DEEP Human Families Blog

Posts

April 17, 2026

New diabetes clinical trial: Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction: A Randomized Crossover Pilot Study

Published on: 2026-04-17T04:00:00Z Conditions : Erectile Dysfunction Interventions : Drug: IncobotulinumtoxinA (100 Units); Other: Placebo Sponsors : Northwestern University; Merz North America, Inc. Not yet recruiting https://ift.tt/QvF9T1Y

Search This Blog

The make DEEP Human Families Blog

Posts

UI Health Collaborations and Education

Helping the Crippled 2 God

The Temple of TRANCE Health Portal

TRANCEatable by Pharmakon Health Cloud

Emergent APHID Helpful Resources

Make DEEP Humans a Divided Line

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction: A Randomized Crossover Pilot Study

Latest Posts

New diabetes clinical trial: Does Pre-operative Gastric Ultrasound Influence Anaesthetic Decision-Making in Chronic Pain Patients? A Prospective Observational Cohort.

New diabetes clinical trial: Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being

New diabetes clinical trial: Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

New diabetes clinical trial: Intervention for Hearing Health Among Native Americans

New diabetes clinical trial: The Effect of Systemic Factors on Peri-implant Health Status and Clinical Indices

New diabetes clinical trial: AI-based Echocardiography for Detection of Cardiac Amyloidosis

New diabetes clinical trial: Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)

New diabetes clinical trial: Chinese, Overweight or Obesity, Real-World Registry Study

New diabetes clinical trial: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

New diabetes clinical trial: Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab